i

iPierian

2 employees

iPierian is a drug discovery platform that develops therapies for neurodegenerative diseases such as SMA, ALS, and Parkinson’s.

Basic info

Industry

biotechnology

Sectors

Biotechnology
Medical Device
Health Care

Date founded

2007

Funding rounds raised

Total raised

$30M

from 11 investors over 11 rounds

i

iPierian raised undisclosed on January 1, 2017

Investors: Mission BioCapital

i

iPierian raised $30M on September 4, 2013

Investors: Kleiner Perkins, S.R. One Ltd and MPM Capital

i

iPierian raised $29M on November 9, 2010

Investors: ATEL Securities Corporation, Kleiner Perkins, S.R. One Ltd, HCP Ltd, MPM Capital, Biogen Idec and GV

FAQ